Advances in Medicine / 2019 / Article / Tab 1

Research Article

Nocturnal Glycemic Control with New Insulin Glargine 300 U/mL

Table 1

Mean nocturnal glucose level (00:00 AM) and parameters of glycemic variability (00:00–6:00 AM) before and after switching from Gla-100 to Gla-300 for basal insulin therapy.

ParametersTreatment
Gla-100Gla-300 value

Mean nocturnal glucose level (mg/dL)126.1 ± 35.11121 ± 31.230.421
SD (mg/dL)16.21 ± 11.0415.18 ± 9.760.605
CV (%)13.34 ± 9.9512.69 ± 8.020.703
Mean amplitude of glucose excursions55.58 ± 35.3952.09 ± 31.090.581

Data are given as mean ± SD.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.